India has been most watched emerging market for medical devices. Country houses right infrastructure, technical know-how, not to forget regulatory knowledge in comparison to all its peer nation involving China, Thailand, Taiwan, Malaysia and others.
The cherry on cake was PM Modi’s recent Make in India campaign which provides incentives to foreign manufacturers to manufacture in India and levy government support on tax and other reforms. Further, last year’s government eased policy to allow 100% FDI under the automatic route in this sector made the situation more favourable for Indian medtech industry.
Country houses right infrastructure, technical know-how, not to forget regulatory knowledge in comparison to all its peer nation involving China, Thailand, Taiwan, Malaysia and others.
This streamlined flow of activities witnessed a sudden break when government raised a concern demanding medical devices price capping. The authorities wanted essential medical devices that are flagged to critical care, to have their price contained in order to make the devices affordable for patients across country.
Teams flagged to the process are likely to sit on the same, and come to the conclusion of how they will balance patients and manufacturers expectation. While one requests for affordability other looks for making cash in order to promote innovation.
Governing bodies are stuck in dilemma, root cause of which comes from the fact seeded to price disparity between indigenous and foreign brands.Foreign manufacturers respond to this by putting the quality difference reason as explanation to higher price quotes.
Call on the final hearing is subjective, and has put the governing agencies at tough spot. As we await for the final call, the prevailing situation leaves a lot of room for discussion around what is ideal thing to do.
For more trends follow:
〈Medical Device Trends〉
Your On-line Trend Tracker